Effect of GnRH conjugated to pokeweed antiviral protein on reproductive function in adult male dogs

K. Sabeur, B. A. Ball, T. M. Nett, H. H. Ball, Irwin Liu

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This study evaluated the effect of a GnRH analogue conjugated to the cytotoxin, pokeweed antiviral protein (PAP), on reproductive function in adult, male dogs. Four dogs received 0.0042 mg GnRH-PAP kg-1 hourly for 36 h, and four other dogs received 0.1 mg GnRH-PAP kg-1 as one bolus injection daily for three consecutive days. One dog received a single bolus (0.1 mg kg-1). Three adult male dogs received GnRH without the PAP conjugate, as controls. Twenty-five weeks after the initial treatment, all treated dogs received 0.1 mg GnRH-PAP kg-1 as a single administration, whereas dogs in the control group received 0.0045 mg kg-1 of the GnRH analogue. Serum concentrations of testosterone and LH were determined by radioimmunoassay, and testis size was measured for 9 months after treatment. Stimulation tests (5 μg GnRH kg-1) were used to evaluate LH release (-15, 0, 30, 60, 90, 120 min), which was assessed by measuring area under the curve. Serum testosterone concentrations were significantly lower (P < 0.05) after treatment in the bolus and hourly groups than in the control group. Testosterone concentrations fell to less than 50 pg ml-1 in three of four dogs in the bolus group and one of four dogs in the hourly group by week 8-9 after treatment. Basal LH was lower (P < 0.05) in the bolus and hourly groups than in the control group between weeks 0 and 33 after treatment. Treatment with GnRH-PAP reduced (P < 0.05) LH release after GnRH stimulation in the bolus and hourly groups compared with the control group. Testis volume was lower (P < 0.05) in all treated versus control dogs. In conclusion, administration of the conjugate GnRH-PAP at a 25 week interval resulted in a major disruption of reproductive parameters in male dogs; this effect was maintained for 11-12 weeks after a second injection of GnRH-PAP.

Original languageEnglish (US)
Pages (from-to)801-806
Number of pages6
JournalReproduction
Volume125
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Gonadotropin-Releasing Hormone
Dogs
Testosterone
Control Groups
Testis
pokeweed antiviral protein
Therapeutics
Injections
Cytotoxins
Serum
Area Under Curve
Radioimmunoassay

ASJC Scopus subject areas

  • Reproductive Medicine
  • Embryology
  • Endocrinology
  • Obstetrics and Gynecology
  • Cell Biology

Cite this

Effect of GnRH conjugated to pokeweed antiviral protein on reproductive function in adult male dogs. / Sabeur, K.; Ball, B. A.; Nett, T. M.; Ball, H. H.; Liu, Irwin.

In: Reproduction, Vol. 125, No. 6, 01.06.2003, p. 801-806.

Research output: Contribution to journalArticle

Sabeur, K. ; Ball, B. A. ; Nett, T. M. ; Ball, H. H. ; Liu, Irwin. / Effect of GnRH conjugated to pokeweed antiviral protein on reproductive function in adult male dogs. In: Reproduction. 2003 ; Vol. 125, No. 6. pp. 801-806.
@article{86e2a82ad8f5467cb3e733e0e3f42059,
title = "Effect of GnRH conjugated to pokeweed antiviral protein on reproductive function in adult male dogs",
abstract = "This study evaluated the effect of a GnRH analogue conjugated to the cytotoxin, pokeweed antiviral protein (PAP), on reproductive function in adult, male dogs. Four dogs received 0.0042 mg GnRH-PAP kg-1 hourly for 36 h, and four other dogs received 0.1 mg GnRH-PAP kg-1 as one bolus injection daily for three consecutive days. One dog received a single bolus (0.1 mg kg-1). Three adult male dogs received GnRH without the PAP conjugate, as controls. Twenty-five weeks after the initial treatment, all treated dogs received 0.1 mg GnRH-PAP kg-1 as a single administration, whereas dogs in the control group received 0.0045 mg kg-1 of the GnRH analogue. Serum concentrations of testosterone and LH were determined by radioimmunoassay, and testis size was measured for 9 months after treatment. Stimulation tests (5 μg GnRH kg-1) were used to evaluate LH release (-15, 0, 30, 60, 90, 120 min), which was assessed by measuring area under the curve. Serum testosterone concentrations were significantly lower (P < 0.05) after treatment in the bolus and hourly groups than in the control group. Testosterone concentrations fell to less than 50 pg ml-1 in three of four dogs in the bolus group and one of four dogs in the hourly group by week 8-9 after treatment. Basal LH was lower (P < 0.05) in the bolus and hourly groups than in the control group between weeks 0 and 33 after treatment. Treatment with GnRH-PAP reduced (P < 0.05) LH release after GnRH stimulation in the bolus and hourly groups compared with the control group. Testis volume was lower (P < 0.05) in all treated versus control dogs. In conclusion, administration of the conjugate GnRH-PAP at a 25 week interval resulted in a major disruption of reproductive parameters in male dogs; this effect was maintained for 11-12 weeks after a second injection of GnRH-PAP.",
author = "K. Sabeur and Ball, {B. A.} and Nett, {T. M.} and Ball, {H. H.} and Irwin Liu",
year = "2003",
month = "6",
day = "1",
doi = "10.1530/rep.0.1250801",
language = "English (US)",
volume = "125",
pages = "801--806",
journal = "Reproduction",
issn = "1470-1626",
publisher = "BioScientifica Ltd.",
number = "6",

}

TY - JOUR

T1 - Effect of GnRH conjugated to pokeweed antiviral protein on reproductive function in adult male dogs

AU - Sabeur, K.

AU - Ball, B. A.

AU - Nett, T. M.

AU - Ball, H. H.

AU - Liu, Irwin

PY - 2003/6/1

Y1 - 2003/6/1

N2 - This study evaluated the effect of a GnRH analogue conjugated to the cytotoxin, pokeweed antiviral protein (PAP), on reproductive function in adult, male dogs. Four dogs received 0.0042 mg GnRH-PAP kg-1 hourly for 36 h, and four other dogs received 0.1 mg GnRH-PAP kg-1 as one bolus injection daily for three consecutive days. One dog received a single bolus (0.1 mg kg-1). Three adult male dogs received GnRH without the PAP conjugate, as controls. Twenty-five weeks after the initial treatment, all treated dogs received 0.1 mg GnRH-PAP kg-1 as a single administration, whereas dogs in the control group received 0.0045 mg kg-1 of the GnRH analogue. Serum concentrations of testosterone and LH were determined by radioimmunoassay, and testis size was measured for 9 months after treatment. Stimulation tests (5 μg GnRH kg-1) were used to evaluate LH release (-15, 0, 30, 60, 90, 120 min), which was assessed by measuring area under the curve. Serum testosterone concentrations were significantly lower (P < 0.05) after treatment in the bolus and hourly groups than in the control group. Testosterone concentrations fell to less than 50 pg ml-1 in three of four dogs in the bolus group and one of four dogs in the hourly group by week 8-9 after treatment. Basal LH was lower (P < 0.05) in the bolus and hourly groups than in the control group between weeks 0 and 33 after treatment. Treatment with GnRH-PAP reduced (P < 0.05) LH release after GnRH stimulation in the bolus and hourly groups compared with the control group. Testis volume was lower (P < 0.05) in all treated versus control dogs. In conclusion, administration of the conjugate GnRH-PAP at a 25 week interval resulted in a major disruption of reproductive parameters in male dogs; this effect was maintained for 11-12 weeks after a second injection of GnRH-PAP.

AB - This study evaluated the effect of a GnRH analogue conjugated to the cytotoxin, pokeweed antiviral protein (PAP), on reproductive function in adult, male dogs. Four dogs received 0.0042 mg GnRH-PAP kg-1 hourly for 36 h, and four other dogs received 0.1 mg GnRH-PAP kg-1 as one bolus injection daily for three consecutive days. One dog received a single bolus (0.1 mg kg-1). Three adult male dogs received GnRH without the PAP conjugate, as controls. Twenty-five weeks after the initial treatment, all treated dogs received 0.1 mg GnRH-PAP kg-1 as a single administration, whereas dogs in the control group received 0.0045 mg kg-1 of the GnRH analogue. Serum concentrations of testosterone and LH were determined by radioimmunoassay, and testis size was measured for 9 months after treatment. Stimulation tests (5 μg GnRH kg-1) were used to evaluate LH release (-15, 0, 30, 60, 90, 120 min), which was assessed by measuring area under the curve. Serum testosterone concentrations were significantly lower (P < 0.05) after treatment in the bolus and hourly groups than in the control group. Testosterone concentrations fell to less than 50 pg ml-1 in three of four dogs in the bolus group and one of four dogs in the hourly group by week 8-9 after treatment. Basal LH was lower (P < 0.05) in the bolus and hourly groups than in the control group between weeks 0 and 33 after treatment. Treatment with GnRH-PAP reduced (P < 0.05) LH release after GnRH stimulation in the bolus and hourly groups compared with the control group. Testis volume was lower (P < 0.05) in all treated versus control dogs. In conclusion, administration of the conjugate GnRH-PAP at a 25 week interval resulted in a major disruption of reproductive parameters in male dogs; this effect was maintained for 11-12 weeks after a second injection of GnRH-PAP.

UR - http://www.scopus.com/inward/record.url?scp=0038007919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038007919&partnerID=8YFLogxK

U2 - 10.1530/rep.0.1250801

DO - 10.1530/rep.0.1250801

M3 - Article

C2 - 12773102

AN - SCOPUS:0038007919

VL - 125

SP - 801

EP - 806

JO - Reproduction

JF - Reproduction

SN - 1470-1626

IS - 6

ER -